EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Twenty years of modelling NPM-ALK-induced lymphomagenesis

Sylvie Giuriato, Suzanne D Turner

Frontiers in Bioscience · 2015 · 7 (2) · 236-247

DOI: 10.2741/s437 ↗

At a glance

Übersichtsarbeit in Frontiers in Bioscience, 2015. Written by Sylvie Giuriato and 1 co-authors. Institution: Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Lab Block Level 3, Box 231, Addenbrooke's Hospital, Cambridge…. Major MEDLINE topics: Disease Models, Animal. Cited 3 times so far (Crossref).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Our current understanding of oncogenic Anaplastic Lymphoma Kinase (ALK)-induced lymphomagenesis has relied for over 20 years on multiple and complementary studies performed on various experimental models, encompassing ALK oncogene expressing cells, their grafts into immune-compromised mice, the generation of genetically engineered mouse models (GEMMs) and, when available, the use of patient samples from Anaplastic Large Cell Lymphoma (ALCL) tumour banks. Of note, and to our knowledge, no ALK-positive ALCL 3D culture system has been described so far. In this review, we will first outline how these different cell and mouse models were designed, and what key findings they revealed (or confirmed) towards oncogenic ALK-induced lymphomagenesis. Secondly, we will discuss how recent and revolutionary advances in genetic engineering technology are likely to complete our understanding of ALK-related disease in an effort to improve current therapeutic approaches.

Subjects

MeSH terms (MEDLINE)

Disease Models, AnimalAnaplastic Lymphoma KinaseAnimalsHumansLymphoma, Large-Cell, AnaplasticMiceMice, TransgenicNuclear ProteinsNucleophosminProtein-Tyrosine KinasesReceptor Protein-Tyrosine Kinases

Substances

Nuclear ProteinsNucleophosminALK protein, humanAlk protein, mouseAnaplastic Lymphoma KinaseProtein-Tyrosine KinasesReceptor Protein-Tyrosine Kinases

Authors and institutions

  • Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Lab Block Level 3, Box 231, Addenbrooke's Hospital, Cambridge CB20QQ, UK, sdt36@cam.ac.uk.

Cite

APA

Giuriato, S., & Turner, S. D. (2015). Twenty years of modelling NPM-ALK-induced lymphomagenesis. Frontiers in Bioscience, 7(2), 236-247. https://doi.org/10.2741/s437

Vancouver

Giuriato S, Turner SD. Twenty years of modelling NPM-ALK-induced lymphomagenesis. Frontiers in Bioscience. 2015;7(2):236-247. doi:10.2741/s437

BibTeX
@article{Giuriato2015,
  author = {Giuriato, Sylvie and Turner, Suzanne D},
  title = {Twenty years of modelling NPM-ALK-induced lymphomagenesis},
  journal = {Frontiers in Bioscience},
  year = {2015},
  volume = {7},
  number = {2},
  pages = {236--247},
  doi = {10.2741/s437}
}
Start for free →